In this study, we detected the alterations in ERK1/2 and STAT3 activation when CKAP2 level was changed in breast cancer cells, suggesting the potential involvement of these two signaling pathways, which awaits detailed characterization in future studies. This evidence concerns the gene CKAP2 and breast cancer.